Nippon Mirai Capital Co., Ltd. through its NMC No. 3 Investment Fund LP agreed to acquire single outpatient care business of Yamane Medical Co., Ltd. (JASDAQ:2144) for ¥4.4 billion in cash on April 1, 2016. Corporate resolution for the transaction was received on April 1, 2016, Plutus Consulting Co., Ltd. acted as appraiser for Yamane Medical.

Nippon Mirai Capital Co., Ltd. through its NMC No. 3 Investment Fund LP completed the acquisition of single outpatient care business of Yamane Medical Co., Ltd. (JASDAQ:2144) on April 4, 2016.